Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1487966
This article is part of the Research Topic Mechanisms and Therapeutic Opportunities of T Cell Impairment in Cancer Immunity and Immunotherapy View all 3 articles

Integrated Analysis of Single-cell, Spatial and Bulk RNAsequencing Identifies a cell-death Signature for Predicting the Outcomes of Head and Neck Squamous Cell Carcinoma

Provisionally accepted
  • 1 Institute of Immunology, Third Military Medical University, Chongqing, China
  • 2 Army Medical University, Chongqing, China
  • 3 The General Hospital of Western Theater Command, department of pharmacology, chengdu, China
  • 4 Western Theater General Hospital, Chengdu, Sichuan Province, China
  • 5 department of pharmacology, chengdu, China
  • 6 Chongqing Medical and Pharmaceutical College, Chongqing, China
  • 7 Dalian University, Dalian, Liaoning Province, China

The final, formatted version of the article will be published soon.

    Background: Cell death plays an essential role in carcinogenesis, but its function in the recurrence and postoperative prognosis of head and neck squamous cell carcinoma (HNSC), which ranks as the 7th most common malignancy globally, remains unclear. Methods: Data from five main subtypes of HNSC related single cell RNA-sequencing (scRNA-seq) were recruited to establish a single-cell atlas, and the distribution of cell death models (CDMs) across different tissues as well as cell subtypes were analyzed. Bulk RNA-seq from the Cancer Genome Atlas Program (TCGA)-HNSC dataset was subjected to a machine learning-based integrative procedure for constructing a consensus cell death-related signature risk score (CDRscore) model and validated by external data. The biofunctions including different expression analysis, immune cell infiltration, genomic mutations, enrichment analysis as well as cellchat analysis were compared between the high- and low- risk score groups categorized by this CDRscore model. Finally, samples from laryngeal squamous cell cancer (LSCC) were conducted by spatial transcriptomics (ST) to further validate the results of CDRscore model. Results: T cells from HNSC patients manifested the highest levels of cell death while HPV infection attenuates malignant cell death based on single-cell atlas. CDMs are positively correlated with the tumor-cell stemness, immune-related score and T cells are infiltrated. A CDRscore model was established based on the transcription of ten cell death prognostic genes (MRPL10, DDX19A, NDFIP1, PCMT1, HPRT1, SLC2A3, EFNB2, HK1, BTG3 and MAP2K7). Its function as an independent prognostic factor for overall survival in HNSC and displays stable and powerful performance validated by GSE41613 and GSE65858 datasets. Patients in high CDRscore manifested worse overall survival, more active of epithelial mesenchymal transition, TGF-β-related pathways and hypoxia, higher transcription of T cell exhausted markers, and stronger TP53 mutation. ST from LSCC showed that spots with high-risk scores were colocalized with TGF-β and the proliferating malignant cells, additionally, the risk scores have a negative correlation with TCR signaling but positive association with LAG3 transcription. Conclusion: The CDRscore model could be utilized as a powerful prognostic indicator for HNSC.

    Keywords: hNSC, Cell Death, machine learning, risk score, Spatial transcriptomics

    Received: 29 Aug 2024; Accepted: 16 Oct 2024.

    Copyright: © 2024 Chen, Pan, Fei, Wang, Chen, Jiang, Li, Wang, Zhang and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Yongwen Chen, Institute of Immunology, Third Military Medical University, Chongqing, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.